Skip to content

ELVEAS: what changed

BE 0442.807.374Other company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
-
not filed
Equity
€19,191
2023 · €19,191
Cash
€18,897
2023 · €18,897
Balance sheet total
€20,342
2023 · €20,342

Largest movements

2023 to 2024
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities

    No liability line moved by more than 1% of the balance sheet total.

      Income statement

      No income-statement line moved by more than 1% of the activity.

        Change in the result, 2023 to 2024

        effect on the result

        The net result is not in both sets of accounts. Without it the difference cannot be explained line by line.

        Derived cash bridge

        cash 2023 to 2024

        Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

        Every line side by side 17 lines
        Line Code 2023 2024 Change %
        Total assets 20/58 €20,342 €20,342 = 0.0%
        Current assets 29/58 €20,342 €20,342 = 0.0%
        Amounts receivable within one year 40/41 €1,445 €1,445 = 0.0%
        Trade receivables 40 €1,362 €1,362 = 0.0%
        Other amounts receivable 41 €83 €83 = 0.0%
        Cash at bank and in hand 54/58 €18,897 €18,897 = 0.0%
        Total equity and liabilities 10/49 €20,342 €20,342 = 0.0%
        Equity 10/15 €19,191 €19,191 = 0.0%
        Contributions 10/11 €18,592 €18,592 = 0.0%
        Capital 10 €18,592 €18,592 = 0.0%
        Issued capital 100 €18,592 €18,592 = 0.0%
        Profit (loss) carried forward 14 €599 €599 = 0.0%
        Amounts payable 17/49 €1,151 €1,151 = 0.0%
        Amounts payable within one year 42/48 €1,151 €1,151 = 0.0%
        Trade debts 44 €1,051 €1,051 = 0.0%
        Suppliers 440/4 €1,051 €1,051 = 0.0%
        Other amounts payable 47/48 €100 €100 = 0.0%

        Value

        latest balance sheet 31-12-2024 · indication, not a valuation or advice

        Indicative value of the equity

        Indication, not a valuation or advice
        €19,191 to €19,191

        Midpoint €19,191 · adjusted equity only

        Capitalisation rate 12% result over 3 years earnings weight 50%

        Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

        Adjusted equity €19,191
        Indication €19,191

        Adjusted equity

        balance sheet 31-12-2024
        Equity (10/15)
        €19,191
        Revaluation of assets
        €0
        Deferred tax on the revaluation
        €0
        Other adjustment
        €0
        Adjusted equity
        €19,191

        Capitalised earnings

        net result for the year (9904)
        2024
        -
        2023
        -
        2022
        -€2
        2021
        -€4
        Average result
        -€3
        Divided by the capitalisation rate
        14% / 12% / 10%
        Capitalised earnings
        not meaningful, as the average result is zero or negative

        Limits of the indication

        • Checked holds no market prices or comparable transactions.
        • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
        • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
        • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
        • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

        For a valuation to base a decision on, go to a company auditor or a certified accountant.

        Calculation and sources

        Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.